|
RAB22A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.53759999971848E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.380600E-04 |
| Normal-vs-Stage2 |
6.106400E-02 |
| Normal-vs-Stage3 |
2.248000E-02 |
| Normal-vs-Stage4 |
1.868990E-01 |
| Stage1-vs-Stage2 |
5.458000E-01 |
| Stage1-vs-Stage3 |
2.840200E-01 |
| Stage1-vs-Stage4 |
3.178400E-01 |
| Stage2-vs-Stage3 |
6.722400E-01 |
| Stage2-vs-Stage4 |
2.722600E-01 |
| Stage3-vs-Stage4 |
1.237590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.24129999995648E-06 |
| Normal-vs-AfricanAmerican |
1.059850E-02 |
| Normal-vs-Asian |
8.402000E-01 |
| Caucasian-vs-AfricanAmerican |
3.596400E-01 |
| Caucasian-vs-Asian |
3.588400E-01 |
| AfricanAmerican-vs-Asian |
4.183200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.25579999999703E-05 |
| Normal-vs-Female |
1.568220E-04 |
| Male-vs-Female |
1.730200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.037830E-01 |
| Normal-vs-Extreme_Weight |
1.889890E-02 |
| Normal-vs-Obese |
9.63750000000374E-05 |
| Normal-vs-Extreme_Obese |
6.824800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.817400E-01 |
| Normal_Weight-vs-Obese |
1.644620E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.717000E-01 |
| Extreme_Weight-vs-Obese |
7.615900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.162200E-01 |
| Obese-vs-Extreme_Obese |
1.343780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.179900E-03 |
| Normal-vs-Age(41-60Yrs) |
2.24710000051864E-07 |
| Normal-vs-Age(61-80Yrs) |
1.685710E-02 |
| Normal-vs-Age(81-100Yrs) |
8.581000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.837600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.242800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.118000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.756000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.357000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.315000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.69773999999512E-05 |
| Normal-VS-Type2 PRCC |
1.089610E-01 |
| Normal-VS-KIRP CIMP |
2.801700E-02 |
| Normal-VS-Unclassified PRCC |
7.426700E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.567390E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.835800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.960000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.451800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.018120E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.317600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.898200E-01 |
| Normal-vs-N1 |
1.057290E-03 |
| Normal-vs-N2 |
1.642550E-01 |
| N0-vs-N1 |
6.758300E-02 |
| N0-vs-N2 |
8.800000E-01 |
| N1-vs-N2 |
4.205600E-01 |
|
|
